HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pattern of ipsilateral breast tumor recurrence after breast-conserving therapy.

AbstractPURPOSE:
To analyze the incidence and prognostic factors of ipsilateral breast tumor recurrence (IBTR) after breast-conserving therapy (BCT) in a large, population-based, single-center study with long-term follow-up.
METHODS AND MATERIALS:
We analyzed 3595 cases in which BCT was performed in 3824 women with stage I or II breast cancer. The incidence of IBTR was analyzed over time and was based on IBTR as first event.
RESULTS:
The 15-year local relapse-free survival was 90.9%. The hazard estimates for IBTR showed a time course with 2 peaks, the first at approximately 5 years and the second, twice as high, at 12 years. Stratifying subjects by age and margin status showed that, for women ≤40 years old with negative margins, adjuvant systemic therapy led to a 5-fold reduced risk of recurrence compared to none, and the presence of lymph vascular space invasion (LVSI) had a 3-fold increased risk compared to its absence. For women >40 years old, the presence of LVSI (hazard ratio [HR] 2.5) and the presence of lobular carcinoma in situ in the lumpectomy specimen (HR 2.3) were the only 2 risk factors.
CONCLUSIONS:
We demonstrated a pattern in risk of IBTR over time, with 2 peaks, first at approximately 5 years and a second, much higher peak at approximately 12 years, especially for women ≤40 years old. For women ≤40 years old with tumor-free resection margins, we noted that the absence of adjuvant systemic therapy and the presence of LVSI were independent prognostic factors of IBTR. For women >40 years old, the presence of LVSI and the presence of lobular carcinoma in situ were independent risk factors.
AuthorsJan Jobsen, Job van der Palen, Sietske Riemersma, Harald Heijmans, Francisca Ong, Henk Struikmans
JournalInternational journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys) Vol. 89 Issue 5 Pg. 1006-1014 (Aug 01 2014) ISSN: 1879-355X [Electronic] United States
PMID25035203 (Publication Type: Journal Article)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Topics
  • Adult
  • Age Factors
  • Aged
  • Axilla
  • Breast Neoplasms (epidemiology, pathology, therapy)
  • Carcinoma in Situ (epidemiology, pathology, therapy)
  • Carcinoma, Lobular (epidemiology, pathology, therapy)
  • Disease-Free Survival
  • Female
  • Humans
  • Incidence
  • Lymph Node Excision
  • Lymph Nodes (pathology)
  • Mastectomy, Segmental
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Invasiveness (pathology)
  • Neoplasm, Residual
  • Neoplasms, Second Primary (epidemiology, pathology)
  • Proportional Hazards Models
  • Prospective Studies
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: